Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-249.47M
↓ 156% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-97.34M
Historical baseline
PeriodValueYoY Change
2025$-249.47M-44.5%
2024$-172.58M-112.1%
2023$-81.36M+49.1%
2022$-159.81M-89.4%
2021$-84.36M-105356.3%
2020$-80000.00-113.3%
2019$601000.00+101.9%
2018$-31.68M-